Calretinin interacts with huntingtin and reduces mutant huntingtin-caused cytotoxicity

Journal of Neurochemistry

Volumn 123, Issue 3, 2012, Pages 437-446

  Dong, Gaofeng ^a   Gross, Kylie ^b   Qiao, Fangfang ^a   Ferguson, Justine ^a   Callegari, Eduardo A ^a   Rezvani, Khosrow ^a   Zhang, Dong ^a   Gloeckner, Christian J ^c,d   Ueffing, Marius ^c,d   Wang, Hongmin ^a  

^a UNIVERSITY OF SOUTH DAKOTA   (United States)

^b Mount Marty College   (United States)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

^d UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

calcium binding protein; calretinin; huntingtin; Huntington's disease; neuroprotection; polyglutamine

Indexed keywords

CALCIUM; CALRETININ; HUNTINGTIN; MUTANT PROTEIN; PROTEIN KINASE B;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; DISEASE MODEL; ENZYME ACTIVATION; GENE SILENCING; HUMAN; HUMAN CELL; HUNTINGTON CHOREA; IMMUNOPRECIPITATION; MOUSE; NERVE CELL CULTURE; NERVE CELL NECROSIS; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; TANDEM AFFINITY PURIFICATION; WILD TYPE;

ANIMALS; CALCIUM-BINDING PROTEIN, VITAMIN D-DEPENDENT; CALCIUM-BINDING PROTEINS; DISEASE MODELS, ANIMAL; DOWN-REGULATION; FEMALE; GENE KNOCKDOWN TECHNIQUES; HEK293 CELLS; HUMANS; HUNTINGTON DISEASE; MALE; MICE; MICE, NEUROLOGIC MUTANTS; NERVE DEGENERATION; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; PRIMARY CELL CULTURE;

EID: 84867337665     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2012.07919.x     Document Type: Article

References (29)

1. Bates G., Harper P., and, Jones L., (2002) Huntington's Disease. Oxford University Press, Oxford.
2. Bodai L., and, Marsh J. L., (2012) A novel target for Huntington's disease: ERK at the crossroads of signaling. The ERK signaling pathway is implicated in Huntington's disease and its upregulation ameliorates pathology. Bioessays, 34, 142-148.
3. Brustovetsky N., LaFrance R., Purl K. J., Brustovetsky T., Keene C. D., Low W. C., and, Dubinsky J. M., (2005) Age-dependent changes in the calcium sensitivity of striatal mitochondria in mouse models of Huntington's Disease. J. Neurochem. 93, 1361-1370. (Pubitemid 40853259)
4. Cicchetti F., Prensa L., Wu Y., and, Parent A., (2000) Chemical anatomy of striatal interneurons in normal individuals and in patients with Huntington's disease. Brain Res. Brain Res. Rev. 34, 80-101.
5. Coticchia C. M., Revankar C. M., Deb T. B., Dickson R. B., and, Johnson M. D., (2009) Calmodulin modulates Akt activity in human breast cancer cell lines. Breast Cancer Res. Treat. 115, 545-560.
6. Dong G., Ferguson J. M., Duling A. J., et al,. (2011) Modeling pathogenesis of Huntington's disease with inducible neuroprogenitor cells. Cell. Mol. Neurobiol. 31, 737-747.
7. Dong G., Callegari E. A., Gloeckner C. J., Ueffing M., and, Wang H., (2012) Prothymosin-alpha interacts with mutant huntingtin and suppresses its cytotoxicity in cell culture. J. Biol. Chem. 287, 1279-1289.
8. Fan M. M., and, Raymond L. A., (2007) N-methyl-D-aspartate (NMDA) receptor function and excitotoxicity in Huntington's disease. Prog. Neurobiol. 81, 272-293. (Pubitemid 46528641)
9. Fedele V., Roybon L., Nordstrom U., Li J. Y., and, Brundin P., (2011) Neurogenesis in the R6/2 mouse model of Huntington's disease is impaired at the level of NeuroD1. Neuroscience 173, 76-81.
10. Gloeckner C. J., Boldt K., Schumacher A., and, Ueffing M., (2009) Tandem affinity purification of protein complexes from mammalian cells by the Strep/FLAG (SF)-TAP tag. Methods Mol. Biol. 564, 359-372.
11. Henzi T., Blum W. V., Pfefferli M., Kawecki T. J., Salicio V., and, Schwaller B., (2009) SV40-induced expression of calretinin protects mesothelial cells from asbestos cytotoxicity and may be a key factor contributing to mesothelioma pathogenesis. Am. J. Pathol. 174, 2324-2336.
12. Holmes D., (2011) PI3K pathway inhibitors approach junction. Nat. Rev. Drug Discovery 10, 563-564.
13. June C. H., and, Rabinovitch P. S., (1994) Intracellular ionized calcium. Methods Cell Biol. 41, 149-174.
14. Li S. H., and, Li X. J., (2004) Huntingtin and its role in neuronal degeneration. The Neuroscientist: a review journal bringing neurobiology, neurology and psychiatry 10, 467-475.
15. Lukas W., and, Jones K. A., (1994) Cortical neurons containing calretinin are selectively resistant to calcium overload and excitotoxicity in vitro. Neuroscience 61, 307-316. (Pubitemid 24219009)
16. Mao L., and, Wang J. Q., (2002) Glutamate cascade to cAMP response element-binding protein phosphorylation in cultured striatal neurons through calcium-coupled group I metabotropic glutamate receptors. Mol. Pharmacol. 62, 473-484. (Pubitemid 36329365)
17. Marilley D., and, Schwaller B., (2000) Association between the calcium-binding protein calretinin and cytoskeletal components in the human colon adenocarcinoma cell line WiDr. Exp. Cell Res. 259, 12-22.
18. Massouh M., Wallman M. J., Pourcher E., and, Parent A., (2008) The fate of the large striatal interneurons expressing calretinin in Huntington's disease. Neurosci. Res. 62, 216-224.
19. Panov A. V., Gutekunst C. A., Leavitt B. R., Hayden M. R., Burke J. R., Strittmatter W. J., and, Greenamyre J. T., (2002) Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines. Nat. Neurosci. 5, 731-736. (Pubitemid 34827590)
20. Rigaut G., Shevchenko A., Rutz B., Wilm M., Mann M., and, Seraphin B., (1999) A generic protein purification method for protein complex characterization and proteome exploration. Nat. Biotechnol. 17, 1030-1032. (Pubitemid 29474865)
21. Schwaller B., Meyer M., and, Schiffmann S., (2002) 'New' functions for 'old' proteins: the role of the calcium-binding proteins calbindin D-28k, calretinin and parvalbumin, in cerebellar physiology. Studies with knockout mice. Cerebellum 1, 241-258. (Pubitemid 44133820)
22. Slepko N., Bhattacharyya A. M., Jackson G. R., Steffan J. S., Marsh J. L., Thompson L. M., and, Wetzel R., (2006) Normal-repeat-length polyglutamine peptides accelerate aggregation nucleation and cytotoxicity of expanded polyglutamine proteins. Proc. Nat. Acad. Sci. USA 103, 14367-14372. (Pubitemid 44484756)
23. Sun S., Li F., Gao X., Zhu Y., Chen J., Zhu X., Yuan H., and, Gao D., (2011) Calbindin-D28K inhibits apoptosis in dopaminergic neurons by activation of the PI3-kinase-Akt signaling pathway. Neuroscience 199, 359-367.
24. Tang T. S., Tu H., Chan E. Y., Maximov A., Wang Z., Wellington C. L., Hayden M. R., and, Bezprozvanny I., (2003) Huntingtin and huntingtin-associated protein 1 influence neuronal calcium signaling mediated by inositol-(1,4,5) triphosphate receptor type 1. Neuron 39, 227-239. (Pubitemid 36897546)
25. Tsuboi K., Kimber T. A., and, Shults C. W., (2000) Calretinin-containing axons and neurons are resistant to an intrastriatal 6-hydroxydopamine lesion. Brain Res. 866, 55-64. (Pubitemid 30313007)
26. Tukamoto T., Nukina N., Ide K., and, Kanazawa I., (1997) Huntington's disease gene product, huntingtin, associates with microtubules in vitro. Brain Res. Mol. Brain Res. 51, 8-14. (Pubitemid 27504026)
27. Wang H., Yu S. W., Koh D. W., et al,. (2004) Apoptosis-inducing factor substitutes for caspase executioners in NMDA-triggered excitotoxic neuronal death. J. Neurosci. 24, 10963-10973. (Pubitemid 39602407)
28. Wang H., Lim P. J., Yin C., Rieckher M., Vogel B. E., and, Monteiro M. J., (2006) Suppression of polyglutamine-induced toxicity in cell and animal models of Huntington's disease by ubiquilin. Hum. Mol. Genet. 15, 1025-1041. (Pubitemid 43338242)
29. Zeron M. M., Hansson O., Chen N., Wellington C. L., Leavitt B. R., Brundin P., Hayden M. R., and, Raymond L. A., (2002) Increased sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease. Neuron 33, 849-860. (Pubitemid 34246352)